Author Correction: CPSF3-dependent pre-mRNA processing as a druggable node in AML and Ewing's sarcoma.

• Ross NT Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
• Lohmann F Novartis Institutes for BioMedical Research, Basel, Switzerland.
• Carbonneau S Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
• Fazal A Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
• Weihofen WA Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
• Gleim S Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
• Salcius M Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
• Sigoillot F Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
• Henault M Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
• Carl SH Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
• Rodríguez-Molina JB Medical Research Council Laboratory of Molecular Biology, Cambridge, UK.
• Miller HR Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
• Brittain SM Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
• Murphy J Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
• Zambrowski M Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
• Boynton G Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
• Wang Y Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
• Chen A Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
• Molind GJ Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
• Wilbertz JH Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
• Artus-Revel CG Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
• Jia M Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
• Akinjiyan FA Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
• Turner J Novartis Institutes for BioMedical Research, Basel, Switzerland.
• Knehr J Novartis Institutes for BioMedical Research, Basel, Switzerland.
• Carbone W Novartis Institutes for BioMedical Research, Basel, Switzerland.
• Schuierer S Novartis Institutes for BioMedical Research, Basel, Switzerland.
• Reece-Hoyes JS Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
• Xie K Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
• Saran C Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
• Williams ET Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
• Roma G Novartis Institutes for BioMedical Research, Basel, Switzerland.
• Spencer M Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
• Jenkins J Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
• George EL Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
• Thomas JR Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
• Michaud G Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
• Schirle M Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
• Tallarico J Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
• Passmore LA Medical Research Council Laboratory of Molecular Biology, Cambridge, UK.
• Chao JA Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
• Beckwith REJ Novartis Institutes for BioMedical Research, Cambridge, MA, USA. rohan.beckwith@novartis.com.

Cell Biology

Molecular Biology